作者
Julie A Campbell, Steve Simpson Jr, Hasnat Ahmad, Bruce V Taylor, Ingrid van der Mei, Andrew J Palmer
发表日期
2020/10
期刊
Multiple Sclerosis Journal
卷号
26
期号
11
页码范围
1315-1328
出版商
SAGE Publications
简介
Objective
Determine the prevalence of multiple sclerosis (MS) in Australia in 2017 using MS-specific disease-modifying therapy (DMT) prescription data and estimate the change in prevalence from 2010.
Methods
DMT prescriptions were extracted from Australia’s Pharmaceutical Benefits Scheme (PBS) data for January–December 2017. Percentages of people with MS using DMTs (DMT penetrance) were calculated using data from the Australian MS Longitudinal Study. Prevalence was estimated by dividing the total number of monthly prescriptions by 12 (except alemtuzumab), adjusted for DMT penetrance and Australian population estimates. Prevalences in Australian states/territories were age-standardised to the Australian population. Comparisons with 2010 prevalence data were performed using Poisson regression.
Results
Overall DMT penetrance was 64%, and the number of people with MS in Australia in …
学术搜索中的文章
JA Campbell, S Simpson Jr, H Ahmad, BV Taylor… - Multiple Sclerosis Journal, 2020